These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 15934835)
1. A review of tositumomab and I(131) tositumomab radioimmunotherapy for the treatment of follicular lymphoma. Davies AJ Expert Opin Biol Ther; 2005 Apr; 5(4):577-88. PubMed ID: 15934835 [TBL] [Abstract][Full Text] [Related]
4. A clinical and scientific overview of tositumomab and iodine I 131 tositumomab. Zelenetz AD Semin Oncol; 2003 Apr; 30(2 Suppl 4):22-30. PubMed ID: 12728404 [TBL] [Abstract][Full Text] [Related]
5. Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma. Vose JM Oncologist; 2004; 9(2):160-72. PubMed ID: 15047920 [TBL] [Abstract][Full Text] [Related]
6. Tositumomab and iodine-131 tositumomab produces durable complete remissions in a subset of heavily pretreated patients with low-grade and transformed non-Hodgkin's lymphomas. Fisher RI; Kaminski MS; Wahl RL; Knox SJ; Zelenetz AD; Vose JM; Leonard JP; Kroll S; Goldsmith SJ; Coleman M J Clin Oncol; 2005 Oct; 23(30):7565-73. PubMed ID: 16186600 [TBL] [Abstract][Full Text] [Related]
7. The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab. Wahl RL Semin Oncol; 2003 Apr; 30(2 Suppl 4):31-8. PubMed ID: 12728405 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy with tositumomab and iodine-131 tositumomab for low-grade non-Hodgkin lymphoma: nursing implications. Estes JM; Clapp KJ Oncol Nurs Forum; 2004 Nov; 31(6):1119-26. PubMed ID: 15547634 [TBL] [Abstract][Full Text] [Related]
9. 131I-tositumomab therapy as initial treatment for follicular lymphoma. Kaminski MS; Tuck M; Estes J; Kolstad A; Ross CW; Zasadny K; Regan D; Kison P; Fisher S; Kroll S; Wahl RL N Engl J Med; 2005 Feb; 352(5):441-9. PubMed ID: 15689582 [TBL] [Abstract][Full Text] [Related]
10. Dose-attenuated radioimmunotherapy with tositumomab and iodine 131 tositumomab in patients with recurrent non-Hodgkin's lymphoma (NHL) and extensive bone marrow involvement. Mones JV; Coleman M; Kostakoglu L; Furman RR; Chadburn A; Shore TB; Muss D; Stewart P; Kroll S; Vallabhajosula S; Goldsmith SJ; Leonard JP Leuk Lymphoma; 2007 Feb; 48(2):342-8. PubMed ID: 17325895 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma. Ghobrial I; Witzig T Oncology (Williston Park); 2004 May; 18(5):623-30; discussion 633-4, 637-8, 640. PubMed ID: 15209190 [TBL] [Abstract][Full Text] [Related]
12. Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma. Leonard JP; Coleman M; Kostakoglu L; Chadburn A; Cesarman E; Furman RR; Schuster MW; Niesvizky R; Muss D; Fiore J; Kroll S; Tidmarsh G; Vallabhajosula S; Goldsmith SJ J Clin Oncol; 2005 Aug; 23(24):5696-704. PubMed ID: 16110029 [TBL] [Abstract][Full Text] [Related]
13. Feasibility and safety of outpatient Bexxar therapy (tositumomab and iodine I 131 tositumomab) for non-Hodgkin's lymphoma based on radiation doses to family members. Rutar FJ; Augustine SC; Kaminski MS; Wahl RL; Siegel JA; Colcher D Clin Lymphoma; 2001 Dec; 2(3):164-72. PubMed ID: 11779293 [TBL] [Abstract][Full Text] [Related]
14. Re-treatment with I-131 tositumomab in patients with non-Hodgkin's lymphoma who had previously responded to I-131 tositumomab. Kaminski MS; Radford JA; Gregory SA; Leonard JP; Knox SJ; Kroll S; Wahl RL J Clin Oncol; 2005 Nov; 23(31):7985-93. PubMed ID: 16204016 [TBL] [Abstract][Full Text] [Related]